What are the leading stocks in the medical sector

Medical sector is one of the hot spots in recent years, this year is even stronger. Data show that the cumulative increase in the medical and biological index during the year has reached 32.66%, far ahead of other major industry indices. So, what are the leading stocks in the medical sector? Come and learn about it ~ 1. General medicine leader: 600276 Hengrui Medicine Hengrui Medicine is a collection of scientific research, production, sales as one of the large-scale pharmaceutical listed companies, is China's largest scientific research and production base of antineoplastic drugs and surgical drugs, is currently one of China's most innovative large-scale pharmaceutical enterprises. The company's main products are antitumor drugs, cardiovascular drugs, surgical drugs, endocrine drugs, etc. 2. Traditional Chinese medicine leader: 000538 Yunnan Baiyao Yunnan Baiyao Group Co., Ltd. formerly known as Yunnan Baiyao Factory was founded in 1971, is the largest, strongest, best brand of pharmaceutical enterprise groups in Yunnan Province. The company's business includes research, production and sales of chemical raw materials, chemical preparations, proprietary Chinese medicines, Chinese herbal medicines, biological products, health food, cosmetics and beverages; it also involves the field of medical devices and daily chemical products.3. Leading Blood Products:002007Hualan BioHualan Bio, founded in 1992, is a national key high-tech enterprise engaged in the research, development and production of blood products.1998. In 1998, Hualan Bio became the first enterprise in China that passed the GMP certification in blood products industry. As a national designated large-scale biological products manufacturer, Hualan Bio has strong technical development strength, leading technology level, first-class production and testing equipment, scientific and standardized management, and perfect quality assurance system, which is in a leading position in the domestic enterprises in the same industry.4. Vaccine leader:300122 Zhifei BiologicalsZhifei Biologicals is a high-tech company mainly engaged in the development and management of biotechnology, integrating scientific research, production and sales as a whole. High-tech company. The company distributes A + C meningococcal polysaccharide conjugate vaccine, A + C + Y + W135 meningococcal polysaccharide vaccine, Haemophilus influenzae type B conjugate vaccine, lyophilized live attenuated hepatitis A vaccine, microcard and other products (some of the above products for the exclusive production and sale of the country, there is no competition for similar products in the country). At present, Zhifei biological new crown pneumonia vaccine has been conditionally approved for marketing or emergency use, which marks China in the new crown pneumonia vaccine research and development and industrialization level of the world's first. 5. Pharmaceutical R & amp; D leader: 603259 WuXi Kande WuXi Kande is a full range of new drugs, integrated R & amp; D and production services company. The company is committed to promoting the process of new drug R&D. Its service scope covers chemical drug R&D and production, cell and gene therapy R&D and production, medical device testing and other fields. WuXi AppTec's empowerment platform is carrying R&D and innovation projects from more than 5,200 partners in more than 30 countries around the world, and is committed to bringing more new medicines and good medicines to patients around the world, and realizing the vision of "making the world free of difficult medicines and difficult illnesses" as soon as possible.6. Medical Device Leader:300760Myriad Healthcare Myriad Medical is China's leading R&D and high-tech medical equipment manufacturers, but also one of the world's medical device innovation leader. The company is committed to R & amp; D and clinical medical equipment manufacturing, its products cover four major areas: life information and support, clinical examination and reagents, digital ultrasound and radiography. The company insists on investing about 10% of its annual turnover to support product innovation and R&D. It has established an R&D management platform that is synchronized with the international first-class level, and its R&D management process is in line with CE, FDA standards and ISO system.